Pivotal Therapeutics Inc (PVTTF: OTCQX International) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pivotal Therapeutics Inc (PVTTF: OTCQX International) | Pivotal Therapeutics issues correction to 2013 financial results press release Pivotal Therapeutics issues correction to 2013 financial results press release

Pivotal Therapeutics issues correction to 2013 financial results press release

Canada NewsWire

WOODBRIDGE, ON , May 1, 2014 /CNW/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announces a correction to its press release issued yesterday entitled "Pivotal Therapeutics Announces 2013 Financial Results".

The decrease in the loss from 2012 to 2013 of $745,342 was inadvertently overstated by $91,520 . The correct decrease in loss is $653,822 and not $745,342 as presented in the press release. All other information remains unchanged. The revised information is as follows:

"For the twelve months ended December 31, 2013 the Company reported a loss of $3.0 million , or $0.04 per common share, compared with a loss of $3.6 million , or $0.05 per common share for the twelve months ended December 31, 2012 . The decrease in loss of $653,822 is attributed to the improvement in revenues combined with a reduction in operating expenses."

This correction applies only to the press release issued effective April 30, 2014 .

About Pivotal Therapeutics Inc.

Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF) (CSE: PVO) specialty pharmaceutical company with a focus on cardiovascular disease and overall health. Pivotal Therapeutics' lead product VASCAZEN ® is a prescription only medical food formulated to meet the dietary Omega-3 deficient needs of patients with cardiovascular disease through elevating Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) to levels associated with reduced risk of cardiovascular complications. OMAZEN ® is a pharmaceutical grade Omega-3 providing over 90% pure Omega-3 in each capsule for the maintenance of good health. OMAZEN ® is a patented product available for sale and distribution in Canada .

About VASCAZEN ®

VASCAZEN ® is currently available in the U.S. as a prescription only medical food specifically formulated for the dietary management of an Omega-3 deficiency in cardiovascular patients. VASCAZEN ® is a > 90% pure Omega-3 with a proprietary 6:1 EPA:DHA fatty acid formulation, protected by a series of both U.S. and foreign patents.

VASCAZEN ® has been clinically shown to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase of HDL without negative impact on the LDL-C lipid profile.  VASCAZEN ® 's results were achieved with a dose of 3 grams of EPA and DHA per day of a prescription grade, high purity Omega-3.

Disclosure Notice

The information contained in this document is as of May 1, 2014 . This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause Pivotal's actual results to differ materially from those projected in such forward-looking statements. These statements can be identified by the use of words such as "will", "anticipate", "estimate", "expect", "project", "forecast", "intend", "plan", "believe", "project", "potential", and similar expressions with any discussion of future operating or financial performance or events. In particular, factors that could cause actual results to differ materially from those in forward looking statements include the following: Pivotal's inability to obtain additional financing on acceptable terms; growth in costs and expenses; inability to compete with others who provide comparable products; risk that the Company's products will not gain widespread market acceptance; risks relating to the Company's ability to maintain its CSNX listing. Forward-looking statements speak only as of the date made and are not guarantees of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statements contained in this document as a result of new information or future events or developments. CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this information.

SOURCE Pivotal Therapeutics Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 181

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 122

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 203

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Notice: Humacyte Investors Should Act Now

Updated Category News Views 117

Understanding the Investigation into Humacyte Faruqi & Faruqi, LLP, a prominent national law firm specializing in securities litigation, is actively looking into potential claims related to Humacyte, Inc. (NASDAQ: HUMA). This investigation comes as a significant opportunity for investors who may have suffered losses exceeding $75,000 during certain periods of the...

Continue Reading
Marco's Pizza Partners with Karate Kid: Legends for Film Launch

Updated Category News Views 206

Marco's Pizza and Karate Kid: Legends Collaboration In an exciting move to engage fans, Marco's Pizza, one of the fastest-growing pizza franchises, has teamed up with Sony Pictures' Karate Kid: Legends. This collaboration aims to celebrate the cherished Karate Kid series with a mouthwatering promotion that promises to delight both pizza and movie enthusiasts. Delicious...

Continue Reading
Innovative Tactile Makeup Palette Supports Vision Impaired Users

Updated Category News Views 352

Introduction to an Inclusive Beauty Initiative Makeup has long been synonymous with beauty and self-expression, yet it has often excluded a significant segment of the population: those who are blind or have low vision. Recognizing this critical gap, the Shine Foundation has collaborated with Cheekbone Beauty to create a groundbreaking solution in the beauty...

Continue Reading
Carver Bancorp Appoints Donald Felix as New Leader

Updated Category News Views 196

Carver Bancorp Welcomes Donald Felix as President and CEO Carver Bancorp, Inc. has made a significant announcement: Donald Felix is now its President and CEO. This marks an important chapter for Carver, which is well-known for its dedication to supporting underserved communities. A Legacy of Service and Community Investment Established in 1948, Carver has consistently led...

Continue Reading
Navigating Merger Concerns with SpartanNash Company Insights

Updated Category News Views 258

Understanding the SpartanNash Merger Situation As the merger of SpartanNash Company (NASDAQ: SPTN) with C&S Wholesale Grocers unfolds, there’s considerable interest in the deal, which proposes a cash buyout of $26.90 per share for SpartanNash shareholders. This sort of transaction can be complex, and it prompts many to wonder whether the offer truly represents a fair...

Continue Reading